Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1864663 (
HCC
)
2,985
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
microRNA (miRNA) plays critical role in
HCC
initiation and development, many miRNAs have been reported to regulate
HCC
progression. In this study, we studied the role of miR-1299 in cell proliferation of
HCC
. We found miR-1299 was significantly downregulated in
HCC
cells and tissues. miR-1299 overexpression inhibited cell proliferation and arrested cell cycle in G0/G1 phase analyzed by MTT assay, soft agar assay, BrdU cell proliferation assay and cell cycle assay, while miR-1299 knockdown promoted cell proliferation and accelerated G1/S transition. Further analysis suggested the key regulator of G1/S transition,
cyclin-dependent kinase 6
(
CDK6
) was the target of miR-1299, miR-1299 inhibited
CDK6
expression and bound to the 3'UTR of
CDK6
. When double knockdown of miR-1299 and
CDK6
promoted cell proliferation copied the phenotype caused by miR-1299 overexpression, suggesting miR-1299 inhibits cell proliferation by targeting
CDK6
. In summary, our data revealed miR-1299 inhibits cell proliferation, and might be a target for
HCC
therapy.
...
PMID:miR-1299 suppresses cell proliferation of hepatocellular carcinoma (HCC) by targeting CDK6. 2749 Jul 80